Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cancer Gene Therapy Market in UK to grow at 20.8% CAGR from 2016 to 2024

Similar presentations


Presentation on theme: "Cancer Gene Therapy Market in UK to grow at 20.8% CAGR from 2016 to 2024"— Presentation transcript:

1 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024 Cancer Gene Therapy Industry share to reach USD 4.3 billion by 2024: Fractovia.org

2 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Cancer Gene Therapy Market growth is driven by Rapid technological breakthroughs and the rising acceptance of newly emerging genomic technologies like next-generation sequencing and high-density DNA microarrays.  For instance, centers for disease control and prevention (CDC) favors countrywide screening programs for breast cancer control and cervical & colorectal cancers among women falling in low-income groups or with no health insurance.  Growing occurrence of cancer across the globe is expected to enrich the demand for gene therapy. As per the WHO report, cases of cancer are projected to increase by half and touch USD 15 million mark by the end of the decade.  Cancer gene treatments are being carried out worldwide through various therapies such as oncolytic virotherapy, gene transfer, and gene induced immunotherapy.  The retroviral vector oncolytic virotherapy segment led the gene therapy industry in 2015 and is predicted to record a CAGR of 20.6% over the period of 2016-2024. Key Insights of Cancer Gene Therapy Market:

3 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  It converts the single-stranded RNA into double-stranded DNA molecule that gradually integrates into the target genome and helps to stimulate the immune system.  The gene transfer therapy segment contributed about 46% of the overall revenue share in 2015 and is predicted to grow at a CAGR of 20.9% over the forecast timeframe.  The U.S. cancer gene therapy market size worth USD 235 million in 2015, is predicted to grow at a CAGR of 20.9% over the forecast timeframe. Factors such as growing cases of cancers and acceptance of advanced methods of cancer treatments are predicted to drive the regional growth.  The China market worth USD 99.6 million in 2015, is predicted to grow at a CAGR of 21% over the forecast period owing to increase in healthcare funding coupled with improvement in R & D facilities.  Key industry participants include Amgen, SiBiono, GENELUX, Altor Bioscience Corporation, MolMed S.p.A, Shanghai Sunway Biotech Company limited, Gradalis, ZIOPHARM Oncology Incorporation, Aduro Biotech Incorporation, GlobeImmune Company, OncoGeneX, and New Link Genetics. Continued…

4 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com U.S. Cancer Gene Therapy Market size, by type, 2012 - 2024 (USD Million)

5 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report Cancer Gene Therapy Market @ http://bit.ly/2jpDwexhttp://bit.ly/2jpDwex Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/204 https://www.fractovia.org/request-sample/204

6 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: https://www.fractovia.org Social Media:


Download ppt "Cancer Gene Therapy Market in UK to grow at 20.8% CAGR from 2016 to 2024"

Similar presentations


Ads by Google